Working… Menu

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03074318
Recruitment Status : Terminated (Terminated due to PI leaving institution)
First Posted : March 8, 2017
Last Update Posted : November 18, 2020
National Cancer Institute (NCI)
EMD Serono
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 15, 2020
Actual Study Completion Date : November 15, 2020